CurveBeam AI (ASX:CVB) Asset Impairment Charge: A$ Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CurveBeam AI Asset Impairment Charge?

CurveBeam AI ASX:CVB Asset Impairment Charge is A$ Mil as of Jun. 2026. The stock has 8 warning signs investors should review.

CurveBeam AI's Asset Impairment Charge for the six months ended in Jun. 2026 was A$ Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 was A$ Mil.

CurveBeam AI Asset Impairment Charge Related Terms

CurveBeam AI Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Asset Impairment Charge Chart

CurveBeam AI Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Asset Impairment Charge
- - - - -

CurveBeam AI Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Asset Impairment Charge Get a 7-Day Free Trial - - - - -

CurveBeam AI Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$ Mil.

What does a Asset Impairment Charge of A$ Mil mean?
CurveBeam AI (ASX:CVB) has a Asset Impairment Charge of A$ Mil as of Jun. 2026.
Is CurveBeam AI's Asset Impairment Charge too high?
CurveBeam AI's current Asset Impairment Charge is A$ Mil.
How does CurveBeam AI's Asset Impairment Charge compare to ABT and SYK?
CurveBeam AI's Asset Impairment Charge of A$ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Medical Devices & Instruments company?
A good Asset Impairment Charge depends on the Medical Devices & Instruments industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. CurveBeam AI's current Asset Impairment Charge is A$ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
Based on GuruFocus' analysis, CurveBeam AI (ASX:CVB) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.09, compared to a current price of A$0.03 — trading 68.9% below its estimated fair value. The current Asset Impairment Charge is A$ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Asset Impairment Charge is A$ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.